[go: up one dir, main page]

EP1572079A3 - Mammalian cdr mimetibodies, compositions, methods and uses - Google Patents

Mammalian cdr mimetibodies, compositions, methods and uses

Info

Publication number
EP1572079A3
EP1572079A3 EP03718053.6A EP03718053A EP1572079A3 EP 1572079 A3 EP1572079 A3 EP 1572079A3 EP 03718053 A EP03718053 A EP 03718053A EP 1572079 A3 EP1572079 A3 EP 1572079A3
Authority
EP
European Patent Office
Prior art keywords
mimetibodies
compositions
methods
cdr
mammalian
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP03718053.6A
Other languages
German (de)
French (fr)
Other versions
EP1572079A4 (en
EP1572079A2 (en
Inventor
George A. Heavner
David M. Knight
Bernard J. Scallon
John Ghrayeb
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Biotech Inc
Original Assignee
Centocor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centocor Inc filed Critical Centocor Inc
Priority claimed from PCT/US2003/009139 external-priority patent/WO2003084477A2/en
Publication of EP1572079A3 publication Critical patent/EP1572079A3/en
Publication of EP1572079A2 publication Critical patent/EP1572079A2/en
Publication of EP1572079A4 publication Critical patent/EP1572079A4/en
Withdrawn legal-status Critical Current

Links

EP03718053A 2002-03-29 2003-03-24 Mammalian cdr mimetibodies, compositions, methods and uses Withdrawn EP1572079A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US36879102P 2002-03-29 2002-03-29
US368791P 2002-03-29
PCT/US2003/009139 WO2003084477A2 (en) 2002-03-29 2003-03-24 Mammalian cdr mimetibodies, compositions, methods and uses

Publications (3)

Publication Number Publication Date
EP1572079A3 true EP1572079A3 (en) 2005-09-09
EP1572079A2 EP1572079A2 (en) 2005-09-14
EP1572079A4 EP1572079A4 (en) 2006-09-06

Family

ID=28791903

Family Applications (1)

Application Number Title Priority Date Filing Date
EP03718053A Withdrawn EP1572079A4 (en) 2002-03-29 2003-03-24 Mammalian cdr mimetibodies, compositions, methods and uses

Country Status (3)

Country Link
EP (1) EP1572079A4 (en)
AU (1) AU2003222069A1 (en)
WO (1) WO2003084477A2 (en)

Families Citing this family (101)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006504406A (en) * 2002-06-28 2006-02-09 セントカー・インコーポレーテツド Mammalian CH1-deficient mimetibodies, compositions, methods and uses
US7897384B2 (en) * 2003-09-08 2011-03-01 Ethicon, Inc. Chondrocyte therapeutic delivery system
US8257963B2 (en) 2007-06-01 2012-09-04 Depuy Mitek, Inc. Chondrocyte container and method of use
US7927599B2 (en) 2003-09-08 2011-04-19 Ethicon, Inc. Chondrocyte therapeutic delivery system
UA89481C2 (en) * 2003-09-30 2010-02-10 Центокор, Инк. Human epo mimetic hinge core mimetibodies, compositions, methods and uses
EP1531162A1 (en) 2003-11-14 2005-05-18 Heinz Vollmers Adenocarcinoma specific antibody SAM-6, and uses thereof
DE10353175A1 (en) 2003-11-14 2005-06-16 Müller-Hermelink, Hans Konrad, Prof. Dr. Human monoclonal antibody with fatliquoring effect
CA2548181A1 (en) * 2003-12-23 2005-07-14 Centocor, Inc. Anti-retroviral agents, compositions, methods and uses
ITMI20041569A1 (en) * 2004-07-30 2004-10-30 Tecnogen Scpa "PEPTIDAL LIGANDS SPECIFIC FOR IMMUNOGLOBULINS"
JP2008537874A (en) 2004-09-27 2008-10-02 セントカー・インコーポレーテツド sRAGE mimetibody, compositions, methods and uses
EP2205280B1 (en) 2007-09-27 2019-09-04 Amgen Inc. Pharmaceutical formulations
EP2219602A1 (en) 2007-11-15 2010-08-25 Amgen, Inc Aqueous formulation of erythropoiesis stimulating protein stablised by antioxidants for parenteral administration
EP2803675A3 (en) 2008-01-25 2014-12-24 Amgen, Inc Ferroportin antibodies and methods of use
CA2722600C (en) 2008-05-01 2014-01-21 Amgen Inc. Anti-hepcidin antibodies and methods of use
CA3019967A1 (en) 2008-11-13 2010-05-20 The General Hospital Corporation Methods and compositions for regulating iron homeostasis by modulation of bmp-6
IT1395137B1 (en) * 2009-08-05 2012-09-05 Spider Biotech S R L NEW ANTIPATOGENIC PEPTIDES
CA2778105C (en) 2009-10-23 2019-04-02 Amgen Inc. Vial adapter and system
CA2800919C (en) 2010-06-07 2019-01-15 Amgen Inc. Drug delivery device
WO2012135315A1 (en) 2011-03-31 2012-10-04 Amgen Inc. Vial adapter and system
AU2012245231B2 (en) 2011-04-20 2016-10-13 Amgen Inc. Autoinjector apparatus
EA030868B1 (en) 2011-10-14 2018-10-31 Эмджен Инк. Injector and method of assembly thereof
US9688723B2 (en) 2012-11-08 2017-06-27 Phi Pharma Sa C4S proteoglycan specific transporter molecules
EP3072548B1 (en) 2012-11-21 2019-03-06 Amgen, Inc Drug delivery device
ES2973257T3 (en) 2013-03-15 2024-06-19 Amgen Inc Drug cassette, autoinjector and autoinjector system
EP3593839A1 (en) 2013-03-15 2020-01-15 Amgen Inc. Drug cassette
CN105142695B (en) 2013-03-15 2020-06-02 安进公司 Body contour adaptable autoinjector device
WO2014152006A2 (en) 2013-03-15 2014-09-25 Intrinsic Lifesciences, Llc Anti-hepcidin antibodies and uses thereof
CA2897825C (en) 2013-03-22 2022-05-24 Scott R. Gibson Injector and method of assembly
US11097055B2 (en) 2013-10-24 2021-08-24 Amgen Inc. Injector and method of assembly
AU2014340174B2 (en) 2013-10-24 2019-09-12 Amgen Inc. Drug delivery system with temperature-sensitive control
US10994112B2 (en) 2014-02-05 2021-05-04 Amgen Inc. Drug delivery system with electromagnetic field generator
CA3193070A1 (en) 2014-05-07 2015-11-12 Amgen Inc. Autoinjector with shock reducing elements
JP6817074B2 (en) 2014-06-03 2021-01-20 アムジエン・インコーポレーテツド Controllable drug delivery system and usage
CA2961917A1 (en) 2014-09-22 2016-03-31 Intrinsic Lifesciences Llc Humanized anti-hepcidin antibodies and uses thereof
JP6766040B2 (en) 2014-10-14 2020-10-07 アムジエン・インコーポレーテツド Lethal injection device with visual and audible indicators
JP2017538512A (en) 2014-12-19 2017-12-28 アムジエン・インコーポレーテツド Drug delivery device including live button or user interface field
EP3848072A1 (en) 2014-12-19 2021-07-14 Amgen Inc. Drug delivery device with proximity sensor
WO2016133947A1 (en) 2015-02-17 2016-08-25 Amgen Inc. Drug delivery device with vacuum assisted securement and/or feedback
ES2905870T3 (en) 2015-02-27 2022-04-12 Amgen Inc Drug delivery device having a needle guard mechanism with an adjustable threshold resistance to movement of the needle guard
WO2017039786A1 (en) 2015-09-02 2017-03-09 Amgen Inc. Syringe assembly adapter for a syringe
EP3386573B1 (en) 2015-12-09 2019-10-02 Amgen Inc. Auto-injector with signaling cap
US11154661B2 (en) 2016-01-06 2021-10-26 Amgen Inc. Auto-injector with signaling electronics
IL302725A (en) * 2016-01-13 2023-07-01 Regeneron Pharma Rodents with an engineered DIVERSITY region of the heavy chain
US11200298B2 (en) 2016-03-15 2021-12-14 Amgen Inc. Reducing probability of glass breakage in drug delivery devices
WO2017189089A1 (en) 2016-04-29 2017-11-02 Amgen Inc. Drug delivery device with messaging label
US11389588B2 (en) 2016-05-02 2022-07-19 Amgen Inc. Syringe adapter and guide for filling an on-body injector
EP3455142B1 (en) 2016-05-13 2023-08-09 Amgen Inc. Vial sleeve assembly
US11238150B2 (en) 2016-05-16 2022-02-01 Amgen Inc. Data encryption in medical devices with limited computational capability
WO2017209899A1 (en) 2016-06-03 2017-12-07 Amgen Inc. Impact testing apparatuses and methods for drug delivery devices
WO2018004842A1 (en) 2016-07-01 2018-01-04 Amgen Inc. Drug delivery device having minimized risk of component fracture upon impact events
US20190328965A1 (en) 2016-08-17 2019-10-31 Amgen Inc. Drug delivery device with placement detection
WO2018081234A1 (en) 2016-10-25 2018-05-03 Amgen Inc. On-body injector
MX2019008432A (en) 2017-01-17 2019-11-18 Amgen Inc Injection devices and related methods of use and assembly.
CA3052204A1 (en) 2017-02-17 2018-08-23 Amgen Inc. Insertion mechanism for drug delivery device
EP3582825A1 (en) 2017-02-17 2019-12-25 Amgen Inc. Drug delivery device with sterile fluid flowpath and related method of assembly
JP2020508803A (en) 2017-03-06 2020-03-26 アムジエン・インコーポレーテツド Drug delivery device with anti-actuation feature
AU2018230546B2 (en) 2017-03-07 2024-03-21 Amgen Inc. Needle insertion by overpressure
CA3052310A1 (en) 2017-03-09 2018-09-13 Amgen Inc. Insertion mechanism for drug delivery device
JP2020511499A (en) 2017-03-20 2020-04-16 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ Method for in vitro glycosylation of erythropoiesis stimulating proteins
KR20240042212A (en) 2017-03-28 2024-04-01 암겐 인코포레이티드 Plunger rod and syringe assembly system and method
AU2018282077B2 (en) 2017-06-08 2023-11-23 Amgen Inc. Torque driven drug delivery device
WO2018226515A1 (en) 2017-06-08 2018-12-13 Amgen Inc. Syringe assembly for a drug delivery device and method of assembly
JP7195276B2 (en) 2017-06-22 2022-12-23 アムジエン・インコーポレーテツド Collision/shock reduction due to device activation
EP3641861A1 (en) 2017-06-23 2020-04-29 Amgen Inc. Electronic drug delivery device comprising a cap activated by a switch assembly
WO2019014014A1 (en) 2017-07-14 2019-01-17 Amgen Inc. Needle insertion-retraction system having dual torsion spring system
IL271173B2 (en) 2017-07-21 2024-04-01 Amgen Inc Gas permeable sealing element for drug container and methods of assembly
EP4085942A1 (en) 2017-07-25 2022-11-09 Amgen Inc. Drug delivery device with gear module and related method of assembly
MA49676A (en) 2017-07-25 2020-06-03 Amgen Inc DRUG ADMINISTRATION DEVICE EQUIPPED WITH A CONTAINER ACCESS SYSTEM AND ASSOCIATED ASSEMBLY PROCEDURE
WO2019032482A2 (en) 2017-08-09 2019-02-14 Amgen Inc. Hydraulic-pneumatic pressurized chamber drug delivery system
WO2019036181A1 (en) 2017-08-18 2019-02-21 Amgen Inc. Wearable injector with sterile adhesive patch
US11103636B2 (en) 2017-08-22 2021-08-31 Amgen Inc. Needle insertion mechanism for drug delivery device
EP3691717B1 (en) 2017-10-04 2023-02-08 Amgen Inc. Flow adapter for drug delivery device
EP3691716B1 (en) 2017-10-06 2023-11-29 Amgen Inc. Drug delivery device with interlock assembly and related method of assembly
EP3694578B1 (en) 2017-10-09 2025-09-24 Amgen Inc. Drug delivery device with drive assembly and related method of assembly
EP3703779A1 (en) 2017-11-03 2020-09-09 Amgen Inc. Systems and approaches for sterilizing a drug delivery device
MA50569A (en) 2017-11-06 2020-09-16 Amgen Inc FILLING-FINISHING UNITS AND ASSOCIATED PROCESSES
US20200261648A1 (en) 2017-11-06 2020-08-20 Amgen Inc. Drug delivery device with placement and flow sensing
EP3706826A1 (en) 2017-11-10 2020-09-16 Amgen Inc. Plungers for drug delivery devices
MA50903A (en) 2017-11-16 2021-05-12 Amgen Inc SELF-INJECTOR WITH STALL AND END POINT DETECTION
SG11202003004RA (en) 2017-11-16 2020-04-29 Amgen Inc Door latch mechanism for drug delivery device
CN108129561B (en) * 2017-12-06 2021-05-25 渤海大学 an ACE inhibitory peptide
US10835685B2 (en) 2018-05-30 2020-11-17 Amgen Inc. Thermal spring release mechanism for a drug delivery device
US11083840B2 (en) 2018-06-01 2021-08-10 Amgen Inc. Modular fluid path assemblies for drug delivery devices
WO2020023451A1 (en) 2018-07-24 2020-01-30 Amgen Inc. Delivery devices for administering drugs
US12303677B2 (en) 2018-07-24 2025-05-20 Amgen Inc. Hybrid drug delivery devices with optional grip portion and related method of preparation
WO2020023336A1 (en) 2018-07-24 2020-01-30 Amgen Inc. Hybrid drug delivery devices with grip portion
CA3103681A1 (en) 2018-07-24 2020-01-30 Amgen Inc. Delivery devices for administering drugs
CA3103105A1 (en) 2018-07-31 2020-02-06 Amgen Inc. Fluid path assembly for a drug delivery device
WO2020068623A1 (en) 2018-09-24 2020-04-02 Amgen Inc. Interventional dosing systems and methods
IL281469B2 (en) 2018-09-28 2024-08-01 Amgen Inc Assembling a memory alloy ejector activation assembly for a drug delivery device
JP2022503983A (en) 2018-10-02 2022-01-12 アムジエン・インコーポレーテツド Injection system for drug delivery with internal force transmission
EP3860686A1 (en) 2018-10-05 2021-08-11 Amgen Inc. Drug delivery device having dose indicator
KR102848295B1 (en) 2018-10-15 2025-08-20 암젠 인크 Drug delivery device with damping mechanism
EA202191038A1 (en) 2018-10-15 2021-07-06 Эмджен Инк. METHOD OF PLATFORM ASSEMBLY FOR MEDICINE DELIVERY DEVICE
EP3873566B1 (en) 2018-11-01 2024-11-27 Amgen Inc. Drug delivery devices with partial drug delivery member retraction
TWI831847B (en) 2018-11-01 2024-02-11 美商安進公司 Drug delivery devices with partial needle retraction and methods for operating the same
MA54057A (en) 2018-11-01 2022-02-09 Amgen Inc DRUG DELIVERY ELEMENT PARTIAL RETRACTION DRUG DELIVERY DEVICES
MX2021012557A (en) 2019-04-24 2021-11-12 Amgen Inc SETS AND METHODS OF VERIFICATION OF STERILIZATION OF SYRINGES.
EP4017560A2 (en) 2019-08-23 2022-06-29 Amgen, Inc Drug delivery device with configurable needle shield engagement components and related methods
BR112023024278A2 (en) 2021-05-21 2024-01-30 Amgen Inc METHOD OF OPTIMIZING A FILLING RECIPE FOR A DRUG CONTAINER
CN120380163A (en) 2022-11-02 2025-07-25 豪夫迈·罗氏有限公司 Method for producing glycoprotein compositions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6955900B1 (en) * 1993-02-02 2005-10-18 The Scripps Research Institute Methods for producing polypeptide binding sites, monoclonal antibodies and compositions thereof
JP2006504406A (en) * 2002-06-28 2006-02-09 セントカー・インコーポレーテツド Mammalian CH1-deficient mimetibodies, compositions, methods and uses

Similar Documents

Publication Publication Date Title
EP1572079A3 (en) Mammalian cdr mimetibodies, compositions, methods and uses
AU2003222069A1 (en) Mammalian cdr mimetibodies, compositions, methods and uses
AU2003262747A1 (en) Compounds, compositions, and methods
AU2003236527A1 (en) Compounds, compositions, and methods
AU2003265242A1 (en) Compounds, compositions, and methods
AU2003270015A1 (en) Compounds, compositions, and methods
AU2003299612A1 (en) Compounds, compositions and methods
EP1545608A4 (en) Mammalian ch1 deleted mimetibodies, compositions, methods and uses
AU2003251858A1 (en) Microbubble compositions, and methods for preparing and using same
AU2003243531A1 (en) Fermentation methods and compositions
EP1542699A4 (en) Compounds, compositions, and methods employing same
AU2003274211A1 (en) Flame-retardant composition, preparation method and use thereof
AU2002253580A1 (en) Modified block copolymer composition
AU2003277079A1 (en) Compounds, compositions, and methods
AU2003256805A1 (en) Compounds compositions and methods
AU2003286474A1 (en) Compositions, solutions, and methods used for transplantation
AU2003266815A1 (en) Immunoglobulin compositions and methods
AU2003290507A1 (en) Compounds, compositions and methods
AU2003297079A1 (en) Anti-filming materials, compositions and methods
AU2003225976A1 (en) Anti-tnf antibodies, compositions, methods and uses
WO2005110009A8 (en) COMPOSITIONS AND METHODS RELATING TO TSP-30a, b, c AND d
WO2004003149A8 (en) Cngh0005 polypeptides, antibodies, compositions, methods and uses
AU2003237332A1 (en) Anti-relp fusion antibodies, compositions, methods and uses
AU2003240281A1 (en) Cell targeting methods and compositions
AU2003300031A1 (en) Compounds, compositions, and methods